Image

Cardiac Amyloidosis in HFpEF Tunisian Patients

Recruiting
60-90 years
Both
Phase N/A
  • Simplified (AI rewritten)
  • Technical (Original)

Cardiac amyloidosis (CA) is a condition where abnormal proteins build up in the heart, making it hard to pump blood properly. In this study, researchers want to find out how common CA is in Tunisian patients with heart failure with preserved ejection fraction (HFpEF). HFpEF means the heart's pumping ability is normal, but it can't fill with enough blood. The study will also look for signs that might predict CA. They'll use clinical exams and ultrasound tests. Eligibility to join the study includes having had HFpEF in the last year and a heart wall thickness of 12 mm or more. You can't join if you're under 60, had a recent heart attack causing HFpEF, or have a birth defect in your heart. 🏥

  • Study Duration: The length of the study is not specified.
  • Visits: Multiple visits may be needed for tests and check-ups.
  • Risks: Some tests might have risks or cause discomfort.
Print
Study details
    Cardiac Amyloidosis
    Heart Failure With Preserved Ejection Fraction
    Echocardiography
    CMR
    Bone Scintigraphy
    Prevalence
    Diagnosis

NCT06201832

University Tunis El Manar

24 January 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.